Bayer AG (OTCPK:BAYRY)
$ 4.97 0.12 (2.47%) Market Cap: 19.06 Bil Enterprise Value: 57.29 Bil PE Ratio: 0 PB Ratio: 0.60 GF Score: 55/100

Q2 2019 Bayer AG Earnings Call Transcript

Jul 30, 2019 / 12:00PM GMT
Release Date Price: $15.96 (-3.97%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor and Analyst Conference Call on the Second Quarter 2019 Results. (Operator Instructions)

And I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations at Bayer. Please go ahead, sir.

O. Maier
Bayer Aktiengesellschaft - Head of IR

Great. Thank you, Emma. Good afternoon, and thanks for joining us today. I'd like to welcome all of you to our second quarter and first half year conference call.

With me on the call today are Werner Baumann, our CEO; and Wolfgang Nickl, our CFO. The businesses are represented as usual by the responsible management Board members. For pharma, we have Stefan Oelrich. For Consumer Health, we have Heiko Schipper. And for Crop Science and Animal Health, we have Liam Condon.

Werner will begin today's call with an overview of the key developments and performance of the various divisions, and Wolfgang will then cover the financials for the second quarter and the outlook as well as our key focus areas for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot